Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Gross Margin (2012 - 2026)

Updated

Phibro Animal Health (PAHC) posted Gross Margin of 33.23% for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 0.32 percentage points from 32.92% a year earlier but down 0.64 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Gross Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Gross Margin at Phibro Animal Health was 33.83%, up 2.66 percentage points year-over-year; for FY2026 (ended Jun 30, 2026), it came in at 33.76%, up 2.91 percentage points from FY2025.

  • Annual Gross Margin has increased for four consecutive fiscal years, with a five-year change of +1.20 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Gross Margin was 30.85% in FY2025 (+0.09 pp), 30.77% in FY2024 (+0.27 pp), 30.50% in FY2023 (+0.21 pp) and 30.29% in FY2022 (-2.28 pp).
  • Quarterly Gross Margin has run from a low of 29.05% in fiscal Q4 2025 to a high of 35.48% in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Gross Margin has increased in each of the last five quarters, with an average year-over-year change of +1.21 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Gross Margin in the past five years was fiscal Q4 2026, with a gain of 4.83 percentage points; the weakest was fiscal Q4 2025, with a drop of 2.85 percentage points.
  • According to Business Quant data, Gross Margin for the three prior fiscal quarters was 33.88% (Q4 2026), 32.77% (Q3 2026) and 35.48% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 68.12%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 75.38%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 72.95%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 88.03%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 73.10%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 81.07%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 75.71%
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 33.23%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 33.23%
Jun 30, 2026 33.88%
Mar 31, 2026 32.77%
Dec 31, 2025 35.48%
Sep 30, 2025 32.92%
Jun 30, 2025 29.05%
Mar 31, 2025 30.06%
Dec 31, 2024 32.94%
Sep 30, 2024 32.06%
Jun 30, 2024 31.90%
Mar 31, 2024 30.24%
Dec 31, 2023 31.45%
Sep 30, 2023 29.27%
Jun 30, 2023 30.06%
Mar 31, 2023 30.75%
Dec 31, 2022 31.63%
Sep 30, 2022 29.52%
Jun 30, 2022 30.72%
Mar 31, 2022 29.89%
Dec 31, 2021 30.37%
API Access

Phibro Animal Health Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=PAHC&period=max&api_key=YOUR_API_KEY